Evidence map›Paper›PMID 25917460›Full record

ArticleJournal of leukocyte biology2015

The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.

Katarzyna Zabieglo, Pawel Majewski, Monika Majchrzak-Gorecka, Agnieszka Wlodarczyk, Beata Grygier, Aneta Zegar, Monika Kapinska-Mrowiecka, Antonina Naskalska, Krzysztof Pyrc, Adam Dubin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. The Multifaceted Roles of Neutrophil Death in COPD and Lung Cancer.Journal of respiratory biology and translational medicine · 2025
    Article
  10. Review
  11. Article
  12. A NovelInternational journal of molecular sciences · 2025
    Article
  13. Article
  14. Article
  15. Neutrophil extracellular traps in homeostasis and disease.Signal transduction and targeted therapy · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Katarzyna Zabieglo*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Pawel Majewski*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Monika Majchrzak-Gorecka*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Agnieszka Wlodarczyk*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Beata Grygier*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Aneta Zegar*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Monika Kapinska-Mrowiecka*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Antonina Naskalska*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Krzysztof Pyrc*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Adam Dubin*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Sharon M Wahl*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Joanna Cichy*Department of Immunology, Department of Microbiology, and Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, and Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Dermatology, Zeromski Hospital, Kraków, Poland; and Cellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA joanna.cichy@uj.edu.pl.
Jagiellonian University · PLNational Institutes of Health · USNational Institute of Dental and Craniofacial Research · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Neutrophil extracellular traps (NETs), web-like DNA structures, provide efficient means of eliminating invading microorganisms but can also present a potential threat to its host because it is a likely source of autoantigens or by promoting bystander tissue damage. Therefore, it is important to identify mechanisms that inhibit NET formation. Neutrophil elastase (NE)-dependent chromatin decondensation is a key event in the release of NETs release. We hypothesized that inhibitors of NE, secretory leukocyte protease inhibitor (SLPI) and α(1)-proteinase inhibitor (α(1)-PI), has a role in restricting NET generation. Here, we demonstrate that exogenous human SLPI, but not α(1)-PI markedly inhibited NET formation in human neutrophils. The ability of exogenous SLPI to attenuate NET formation correlated with an inhibition of a core histone, histone 4 (H4), cleavage, and partial dependence on SLPI-inhibitory activity against NE. Moreover, neutrophils from SLPI(-/-) mice were more efficient at generating NETs than were neutrophils from wild-type mice in vitro, and in experimental psoriasis in vivo. Finally, endogenous SLPI colocalized with NE in the nucleus of human neutrophils in vitro, as well as in vivo in inflamed skin of patients with psoriasis. Together, these findings support a controlling role for SLPI in NET generation, which is of potential relevance to infectious and autoinflammatory diseases.

Indexed as

AdultAnimalsFemaleHumansMaleMiceMice, KnockoutNeutrophilsPsoriasisSecretory Leukocyte Peptidase InhibitorSecretory Leukocyte Peptidase InhibitorSLPI protein, humanautoimmune diseaseinflammationpsoriasisserineskin

Identifiers

PMID25917460
PMCPMC4467168
OpenAlexW2146432243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.